US Patent Issued to CRISPR Therapeutics on Feb. 18 for "Methods and compositions for treating cancer" (Massachusetts Inventors)

ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,227,763, issued on Feb. 18, was assigned to CRISPR Therapeutics AG (Zug, Switzerland).

"Methods and compositions for treating cancer" was invented by Jonathan Alexander Terrett (Cambridge, Mass.), Demetrios Kalaitzidis (Cambridge, Mass.), Mary-Lee Dequeant (Cambridge, Mass.) and Zinkal Samir Padalia (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein, in some embodiments, are methods and compositions (e.g., cell compositions) for the treatment of cancer."

The patent was filed on May 10, 2019, under Application No. 17/054,483.

*For further information, including images, charts and tables, please visit: http://patft.uspto.go...